Nightingale Appoints a New Chief Technology Officer
MARKHAM, ON, July 22, 2014 /CNW/ - Nightingale Informatix Corporation ("Nightingale" or the "Company") (TSX-V: NGH), a cloud-based provider of electronic health record (EHR) software and related services, today announced the appointment of Ray Payette as Chief Technology Officer.
"Nightingale is on the cusp of breaking the adoption barriers in the EHR market with the launch of its next generation platform, NightingaleEHR (Nexia)" said Sam Chebib, President & CEO of Nightingale. "Our drive to be the undisputed technology leader requires special talents at all levels. Ray will lead Nightingale's technology initiatives providing his extensive knowledge and expertise to ensure that Nightingale delivers on its "best-of-breed" promise, remains a leader in the EHR market, and continues to drive new innovations & initiatives in Healthcare."
Having worked at the executive level for North American industry leaders such as IBM and Blueprint Software Systems, Ray brings deep expertise in a broad range of development-related areas, including project and product management, program and software development, product strategy and SaaS deployments.
Formerly a senior officer with the Canadian Air Forces, Ray has applied his unique skills in previous roles as Senior Vice President, Engineering and Operations at Blueprint Software Systems; and a number of Executive Lead roles for IBM Cognos. Among other achievements, he led the team involved in the highly successful Cognos 10 offering. Prior to joining Nightingale, he was responsible for providing management, deployment, vision and strategy expertise to Blueprint Software Systems' product line. He also initiated the development of a Mobile solution for Apple and Android devices as well as an adjacent, patent pending product. Ray holds a BSc from Dalhousie University and several certificates from the Canadian Forces Management School.
As a Company who is a trailblazer investing in the best technology, Nightingale diligently strives to attract the upmost talented executives that will help the company scale the next phase of its growth. The Company's technology and its strengthened management structure have put Nightingale in an excellent position to capitalize on the numerous opportunities it has identified in the healthcare IT market across North America.
About Nightingale
For more than a decade, Nightingale (TSX-V: NGH) has been delivering innovative cloud-based Electronic Health Record (EHR) and Practice Management solutions to healthcare organizations across the United States and Canada. Our goal is to uncomplicate the day-to-day challenges of healthcare providers. We achieve this by creating software that is truly intuitive—minimizing training and maximizing adoption. We believe so strongly in building easy-to-use software that we structured our entire product team around user-centric design. Our clients are benefiting from this focus through a well-supported and robust solution that presents a holistic view of a person's well-being in a simple, clean interface, so that the best health decisions can be made. Nightingale – One Patient. One Record. www.nightingalemd.com
Forward Looking Statement
This press release contains "forward-looking statements" respecting the issuance and cancellation of securities of the Company within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully secure customer contracts and the timing of securing such contracts; the ability of Nightingale to complete and successfully integrate its acquisitions on an accretive basis, Nightingale's access to debt and capital facilities, including compliance with current debt arrangements; the existence of present and possible future government regulation; the significant competition that exists in the medical software industry; the early stage of Nightingale's business, and risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding. All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding future trends in healthcare spending, economic conditions affecting Nightingale and North American economies; Nightingale's ability to continue to fund its business, rates of customer defaults, relationships with, and payments to lenders, as well as Nightingale's operating cost structure.
Although Nightingale has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Nightingale does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws. Further information on Nightingale Informatix Corporation is available at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Nightingale Informatix Corporation
Media Inquiries, Brittany Quemby, Marketing Manager, Nightingale Informatix Corporation, Tel: 905-307-6867, [email protected]; Investor Inquiries, Marc Lakmaaker, Senior Account Executive, TMX Equicom, Tel: 416-815-0700 ext. 248, [email protected]
Share this article